000 01358 a2200349 4500
005 20250517065459.0
264 0 _c20161024
008 201610s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/1381612822666151204000855
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Xiu-Min
245 0 0 _aExperimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2016
300 _a728-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Neutralizing
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aMyelin Proteins
_ximmunology
650 0 4 _aReceptors, Cell Surface
_ximmunology
650 0 4 _aSpinal Cord Injuries
_ximmunology
650 0 4 _aSpinal Cord Regeneration
_ximmunology
650 0 4 _aVaccines, Synthetic
_xtherapeutic use
700 1 _aWei, Jing-Xiang
700 1 _aXiao, Lan
700 1 _aShu, Ya-Hai
700 1 _aWang, Yong-Tang
773 0 _tCurrent pharmaceutical design
_gvol. 22
_gno. 6
_gp. 728-37
856 4 0 _uhttps://doi.org/10.2174/1381612822666151204000855
_zAvailable from publisher's website
999 _c25512760
_d25512760